A study into the effectiveness of a single-session relational skills training

Support and Help for Adolescents in Responding to social Experiences (SHARE): a randomized controlled trial into the effectiveness of a single-session systemic intervention to practise skills for sharing between young people and their loved ones.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN27618741

Enrollment

128

Registered

2026-07-03

Start date

2026-07-07

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality pathology Mental and Behavioural Disorders

Interventions

This study is a randomised controlled trial (RCT) into the effectiveness of the SHARE intervention, a single-session intervention aimed at helping young people and their close others practise skills f

Eligibility

Sex/Gender

All

Age

12 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. Starting treatment at GGz Centraal HYPE (a mental health institution department in the Netherlands for youth with characteristics of personality pathology) 2. Age 12-25 years (inclusive)

Exclusion criteria

Exclusion criteria: 1. Insufficient understanding and skills in the Dutch language

Design outcomes

Primary

Measure	Time frame
Self-disclosure measured using 6-item version of the Utrechtse Coping Lijst (UCL), and 10-item version of the Close Persons Questionnaire (CPQ) at baseline (start of treatment) and after 4 weeks, and an open-ended question on self-disclosure at baseline, immediately after the intervention session (if applicable) and after 4 weeks;Social support measured using 11-item version of the Network of Relationships Inventory-Behavior Systems Version (NRI-BSV) at baseline (start of treatment) and after 4 weeks about all close others that will participate in the SHARE therapy session, and an open-ended question on social support at baseline, immediately after the intervention session (if applicable) and after 4 weeks;Connectedness measured using 8-item version of the Social Connectedness Scale (SCS) at baseline (start of treatment) and after 4 weeks, and an open-ended question on connectedness at baseline, immediately after the intervention session (if applicable) and after 4 weeks	—

Measure

Time frame

Self-disclosure measured using 6-item version of the Utrechtse Coping Lijst (UCL), and 10-item version of the Close Persons Questionnaire (CPQ) at baseline (start of treatment) and after 4 weeks, and an open-ended question on self-disclosure at baseline, immediately after the intervention session (if applicable) and after 4 weeks;Social support measured using 11-item version of the Network of Relationships Inventory-Behavior Systems Version (NRI-BSV) at baseline (start of treatment) and after 4 weeks about all close others that will participate in the SHARE therapy session, and an open-ended question on social support at baseline, immediately after the intervention session (if applicable) and after 4 weeks;Connectedness measured using 8-item version of the Social Connectedness Scale (SCS) at baseline (start of treatment) and after 4 weeks, and an open-ended question on connectedness at baseline, immediately after the intervention session (if applicable) and after 4 weeks

—

Secondary

Measure	Time frame
Satisfaction with the SHARE therapy session measured using the Client Satisfaction Questionnaire-4 (CSQ-4) at baseline (start of treatment) and after 4 weeks;Loneliness measured using the De Jong Gierveld Scale at baseline (start of treatment) and after 4 weeks;Emotion regulation measured using 18-item version of the Difficulties in Emotion Regulation Scale (DERS) at baseline (start of treatment) and after 4 weeks;Quality of life measured using the short version of the Recovering Quality of Life (ReQoL) at baseline (start of treatment) and after 4 weeks;Personality functioning: measured using SCID-II Screener BPD section, Borderline Symptom List – behavioural items (BSL), Levels of Personality Functioning Scale 2.0 (LPFS-BF 2.0) at baseline (start of treatment) and after 4 weeks;Developmental milestones measured using the Developmental Milestones List at baseline (start of treatment) and after 4 weeks;Psychopathology: measured using a Dutch extension of the Strengths and Difficulties Questionnaire; Screeningsinstrument Psychische stoornissen (SPSY) at baseline (start of treatment) and after 4 weeks;Program integrity measured using (open-ended) questions related to program integrity filled out by the young person, close other(s) and therapist at immediately after the intervention session	—

Measure

Time frame

Satisfaction with the SHARE therapy session measured using the Client Satisfaction Questionnaire-4 (CSQ-4) at baseline (start of treatment) and after 4 weeks;Loneliness measured using the De Jong Gierveld Scale at baseline (start of treatment) and after 4 weeks;Emotion regulation measured using 18-item version of the Difficulties in Emotion Regulation Scale (DERS) at baseline (start of treatment) and after 4 weeks;Quality of life measured using the short version of the Recovering Quality of Life (ReQoL) at baseline (start of treatment) and after 4 weeks;Personality functioning: measured using SCID-II Screener BPD section, Borderline Symptom List – behavioural items (BSL), Levels of Personality Functioning Scale 2.0 (LPFS-BF 2.0) at baseline (start of treatment) and after 4 weeks;Developmental milestones measured using the Developmental Milestones List at baseline (start of treatment) and after 4 weeks;Psychopathology: measured using a Dutch extension of the Strengths and Difficulties Questionnaire; Screeningsinstrument Psychische stoornissen (SPSY) at baseline (start of treatment) and after 4 weeks;Program integrity measured using (open-ended) questions related to program integrity filled out by the young person, close other(s) and therapist at immediately after the intervention session

—

Countries

Netherlands

Contacts

Public ContactIsa Swinkels

share@ggzcentraal.nl+31 (0)6-23775602

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026